We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene in Human Egg Essential for Fertility

By Biotechdaily staff writers
Posted on 24 May 2002
A gene in the human egg that appears to be essential for fertility has been discovered by fertility researchers. More...
The finding was reported in the April 2002 issue of Human Reproduction.

The gene may also play a role in premature ovarian failure, a condition in which the ovaries stop functioning for years or decades before natural menopause. Thus the gene may be associated with unexplained infertility in women. The discovery builds on prior research conducted in mice, where researchers found a gene in female mice that they named "Mater,” short for "maternal effect” gene.

The Mater gene produces a protein essential to the development of a fertilized egg. In the current study, a gene was identified in women that appears to be the human counterpart.

While investigating premature ovarian failure, the researchers found that in some cases, the ovaries of healthy women appeared to be attacked and destroyed by their immune systems. Mice with a similar disorder also experience such an attack. The target of the attack is a protein produced by the mouse Mater gene. To investigate this protein's function, the researchers developed a strain of mice that lacked both copies of the gene and found that all the females were infertile. They also found that the DNA of human and mouse Mater genes are 67% identical. The proteins produced by mouse and human Mater genes are 53% identical. Thus, the Mater mutation or its protein deficiency may cause infertility in some women.

”If the human gene is found to serve the same function as the mouse gene, it may result in a new approach to the study and treatment of fertility,” said Lawrence Nelson, M.D., senior author of the study and a member of the developmental endocrinology branch of the US National Institute of Child Health and Human Development (NICHD), which conducted the study.

One avenue of research suggested by the study is to examine women who have a history of successful fertilization but whose embryos fail to develop, to see if they have mutations on the Mater gene. If they do, researchers may one day be able to induce pregnancy by injecting Mater protein into the egg cells of such women before conception.





Related Links:
National Institute of Child Health and Human Development

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.